LPL Financial
QNTM

LPL Financial’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

LPL Financial’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,917
Closed -$221K – 6020
2025
Q2 		$221K Buy
+10,917
New +$135K ﹤0.01% 5012

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CTC
Cetera Trust Company St. Paul, Minnesota $177M AUM 28.75% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

LPL Financial's QNTM Position: Q3 2025 in Review

LPL Financial sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2025, closing a stake of 10,917 shares — an estimated $221K sold.

LPL Financial first reported a position in QNTM in Q2 2025 and held it in 1 quarter. The position peaked at $221K in Q2 2025. 17 funds tracked by Wall St. Rank hold QNTM as of Q3 2025.

  • LPL Financial reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 10,917 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2025, an estimated $221K.
  • LPL Financial first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2025 and held it in 1 quarter.
  • LPL Financial's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $221K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.